2.78
price down icon9.15%   -0.28
after-market Handel nachbörslich: 2.73 -0.05 -1.80%
loading

Editas Medicine Inc Aktie (EDIT) Neueste Nachrichten

pulisher
Nov 04, 2025

Can Editas Medicine Inc. stock sustain market leadershipLong Setup & Fast Entry and Exit Trade Plans - newser.com

Nov 04, 2025
pulisher
Nov 04, 2025

Analyzing Editas Medicine Inc. with risk reward ratio charts2025 AllTime Highs & Real-Time Chart Breakout Alerts - newser.com

Nov 04, 2025
pulisher
Nov 04, 2025

Is Editas Medicine Inc. (8EM) stock expanding market penetrationWeekly Investment Recap & Weekly Return Optimization Plans - newser.com

Nov 04, 2025
pulisher
Nov 04, 2025

Why analysts raise outlook for Editas Medicine Inc. (8EM) stock2025 Market Sentiment & Expert Verified Movement Alerts - newser.com

Nov 04, 2025
pulisher
Nov 04, 2025

Is Editas Medicine Inc. stock attractive after correctionWeekly Trading Summary & Real-Time Volume Analysis - newser.com

Nov 04, 2025
pulisher
Nov 03, 2025

Can Editas Medicine Inc. stock sustain institutional interestWeekly Trade Analysis & Verified Trade Idea Suggestions - newser.com

Nov 03, 2025
pulisher
Nov 03, 2025

Can Editas Medicine Inc. stock withstand economic slowdownJobs Report & Free AI Powered Buy and Sell Recommendations - newser.com

Nov 03, 2025
pulisher
Nov 03, 2025

Should you hold or exit Editas Medicine Inc. nowTrade Exit Summary & Community Consensus Trade Signals - newser.com

Nov 03, 2025
pulisher
Nov 03, 2025

Editas Medicine Announces EDIT-401 Poster Presentation at the American Heart Association (AHA) Scientific Sessions 2025 - The Manila Times

Nov 03, 2025
pulisher
Nov 03, 2025

Will Editas Medicine Inc. stock beat EPS estimatesQuarterly Market Review & Weekly Top Gainers Trade List - newser.com

Nov 03, 2025
pulisher
Nov 03, 2025

Editas Medicine unveils EDIT-401 data at AHA 2025 - Traders Union

Nov 03, 2025
pulisher
Nov 03, 2025

Editas Medicine (Nasdaq: EDIT) to present EDIT-401 LDL-lowering CRISPR poster at AHA 2025 - Stock Titan

Nov 03, 2025
pulisher
Nov 03, 2025

Will Editas Medicine Inc. stock continue upward momentumWeekly Volume Report & High Yield Equity Trading Tips - newser.com

Nov 03, 2025
pulisher
Nov 03, 2025

Can Editas Medicine Inc. stock weather global recessionMarket Performance Summary & Verified Momentum Stock Alerts - newser.com

Nov 03, 2025
pulisher
Nov 03, 2025

Why analysts remain bullish on Editas Medicine Inc. stock2025 Big Picture & Accurate Entry and Exit Point Alerts - newser.com

Nov 03, 2025
pulisher
Nov 03, 2025

Backtesting results for Editas Medicine Inc. trading strategiesJuly 2025 Action & Free Growth Oriented Trading Recommendations - newser.com

Nov 03, 2025
pulisher
Nov 03, 2025

Should I hold or sell Editas Medicine Inc. stock in 2025Portfolio Return Report & Weekly High Momentum Picks - newser.com

Nov 03, 2025
pulisher
Nov 03, 2025

What moving averages say about Editas Medicine Inc.July 2025 Short Interest & Risk Controlled Daily Plans - newser.com

Nov 03, 2025
pulisher
Nov 02, 2025

Institutional scanner results for Editas Medicine Inc.Dip Buying & Stepwise Trade Signal Implementation - newser.com

Nov 02, 2025
pulisher
Nov 02, 2025

Combining price and volume data for Editas Medicine Inc.Wall Street Watch & Risk Managed Investment Signals - newser.com

Nov 02, 2025
pulisher
Nov 02, 2025

How Editas Medicine Inc. (8EM) stock valuation compares with sector2025 Key Highlights & Entry Point Confirmation Alerts - newser.com

Nov 02, 2025
pulisher
Nov 02, 2025

Is Editas Medicine Inc. stock a smart buy before Fed meetingJuly 2025 Earnings & Real-Time Volume Analysis - newser.com

Nov 02, 2025
pulisher
Nov 02, 2025

How Editas Medicine Inc. (8EM) stock responds to job market shiftsGlobal Markets & Daily Price Action Insights - newser.com

Nov 02, 2025
pulisher
Nov 02, 2025

How currency fluctuations impact Editas Medicine Inc. stockPortfolio Gains Report & Weekly Market Pulse Alerts - newser.com

Nov 02, 2025
pulisher
Nov 01, 2025

How to build a dashboard for Editas Medicine Inc. stockWeekly Risk Summary & AI Enhanced Trading Signals - newser.com

Nov 01, 2025
pulisher
Oct 31, 2025

Editas Medicine’s Long-Term Study on EDIT-301: A Potential Game-Changer for Hemoglobinopathies - TipRanks

Oct 31, 2025
pulisher
Oct 31, 2025

How institutional ownership impacts Editas Medicine Inc. stockJuly 2025 Volume & Community Verified Trade Signals - newser.com

Oct 31, 2025
pulisher
Oct 31, 2025

Full technical analysis of Editas Medicine Inc. stockPortfolio Performance Summary & Capital Protection Trading Alerts - newser.com

Oct 31, 2025
pulisher
Oct 31, 2025

Does Editas Medicine Inc. qualify in momentum factor screeningPortfolio Update Report & Weekly Setup with High ROI Potential - newser.com

Oct 31, 2025
$37.84
price up icon 1.45%
$28.76
price up icon 0.17%
$102.92
price up icon 1.33%
$104.83
price up icon 0.84%
biotechnology ONC
$309.19
price down icon 0.86%
$182.77
price down icon 1.86%
Kapitalisierung:     |  Volumen (24h):